Our findings in this study suggest that the maintenance of proteostasis and proper level of PD-L1 in tumor cells is critical for the efficacy of ICI treatment, since excessive PD-L1 molecules exhaust an antitumor immune microenvironment and abrogate the effect of blocking antibodies to evoke positive immunity. Here, CD274 is linked to neoplasm.